文献速递血管炎

利妥昔单抗清除B细胞后抗中性粒细胞胞质抗体相关血管炎中自身反应性浆母细胞与复发的关系

Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
PubMed 文献 · Arthritis Rheumatol · 2023-03-15

该研究对23例接受利妥昔单抗诱导缓解的PR3-ANCA阳性AAV患者进行前瞻性长期随访,用流式细胞术连续检测外周血单个核细胞。发现B细胞重建时自身反应性PR3+ B细胞池组成改变,PR3+浆母细胞频率升高与复发相关,且浆母细胞高于基线者未来12个月内更易复发。

要点

  • B细胞重建时PR3+ B细胞频率高于基线,过渡型和初始亚群升高而记忆亚群降低。
  • 复发患者PR3+ B细胞池中浆母细胞频率更高,且与较短复发时间相关。
  • PR3+浆母细胞频率高于基线者未来12个月内更易复发。

核心结论

  • 利妥昔单抗治疗后AAV患者自身反应性B细胞池组成显著变化,自身反应性池中早期浆母细胞富集与未来复发相关。

研究设计与样本

  • 前瞻性临床试验中,对23例因缓解诱导接受利妥昔单抗治疗的PR3-ANCA阳性AAV患者,在长期随访停药后连续采集148份外周血单个核细胞样本进行流式细胞术检测。

主要发现

  • B细胞重建时,PR3+ B细胞占B细胞频率高于基线(P < 0.01)。
  • B细胞重建时,PR3+和总B细胞中过渡型和初始亚群频率高于基线,记忆亚群低于基线(所有比较P < 0.001)。
  • B细胞重建时,复发患者与持续缓解患者的B细胞及亚群频率无差异。
  • 复发患者PR3+ B细胞池中浆母细胞频率更高,且与较短复发时间相关。
  • PR3+浆母细胞频率高于基线者在未来12个月内复发的可能性高于持续缓解者(P < 0.05)。

关键数值与推荐

  • B细胞重建定义为利妥昔单抗治疗后首次出现≥10个B细胞/μl的血样本。
  • PR3用作配体靶向自身反应性PR3特异性(PR3+)B细胞。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Autoreactive B cells are responsible for antineutrophil cytoplasmic antibody (ANCA) production in ANCA-associated vasculitis (AAV). Rituximab (RTX) depletes circulating B cells, including autoreactive B cells. We aimed to evaluate changes and associations with relapse of the circulating autoreactive B cell pool following therapeutic B cell depletion in AAV. METHODS: Sequential flow cytometry was performed on 148 samples of peripheral blood mononuclear cells from 23 patients with proteinase 3 (PR3)-ANCA-positive AAV who were treated with RTX for remission induction and monitored after stopping therapy during long-term follow-up in a prospective clinical trial. PR3 was used as a ligand to target autoreactive PR3-specific (PR3+) B cells. B cell recurrence was considered as the first blood sample with ≥10 B cells/μl after RTX treatment. RESULTS: At B cell recurrence, PR3+ B cell frequency among B cells was higher than baseline (P < 0.01). Within both PR3+ and total B cells, frequencies of transitional and naive subsets were higher at B cell recurrence than at baseline, while memory subsets were lower (P < 0.001 for all comparisons). At B cell recurrence, frequencies of B cells and subsets did not differ between patients who experienced relapse and patients who remained in remission. In contrast, the plasmablast frequency within the PR3+ B cell pool was higher in patients who experienced relapse and associated with a shorter time to relapse. Frequencies of PR3+ plasmablasts higher than baseline were more likely to be found in patients who experienced relapse within the following 12 months compared to those in sustained remission (P < 0.05). CONCLUSION: The composition of the autoreactive B cell pool varies significantly following RTX treatment in AAV, and early plasmablast enrichment within the autoreactive pool is associated with future relapses.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Berti A, Hillion S, Konig MF, et al. Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2023. PMID: 36281741. doi:10.1002/art.42388

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。